SUPPORT-Canada: CanPath’s COVID‑19 Surveillance Initiative

Speakers: Dr. Philip Awadalla, National Scientific Director of CanPath, and Senior Investigator, Ontario Institute for Cancer Research, and Dr. John McLaughlin, Executive Director of CanPath, and Professor, Dalla Lana School of Public Health

As Canada’s largest population health study, the Canadian Partnership for Tomorrow’s Health (CanPath) responded quickly to the pandemic by leveraging its existing infrastructure to capture COVID‑19 related data and biospecimens from the Canadian population to identify factors contributing to COVID‑19 susceptibility, severity, and outcomes across Canada. In this talk, Dr. Awadalla and Dr. McLaughlin describe new data based on over 100,000 participant responses to the CanPath COVID‑19 Questionnaire in 2020, as well as preliminary analyses of questionnaire data and immunity test results from blood samples collected in spring 2021. The presentation also describes how researchers can access CanPath’s COVID‑19 related data, along with nationally harmonized baseline and follow-up cohort data, through the CanPath Portal.

________________________________________________________________________________

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback